NOX inhibitors (Calliditas Therapeutics)

N/A

Report date: 2025/03/20 09:12:08
NME

Base Information

Drug NameNOX inhibitors (Calliditas Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADPH oxidase inhibitors
TargetsNADPH oxidase
Therapy Area/IndicationsCholangitis, SclerosingHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCalliditas Therapeutics Ab
China Registration ClassN/A

Develop Information

Active CompaniesCalliditas Therapeutics Ab
Inactive CompaniesN/A
Active IndicationsCholangitis, SclerosingHead and Neck Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A